HIGHLIGHTS
- who: Anthony Turpin and colleagues from the UMR9020-UMR-S , Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, University of, CNRS, Inserm, CHU, Institut Pasteur de, France have published the paper: Localized Small Bowel Adenocarcinoma Management: Evidence Summary, in the Journal: Cancers 2022, 14, 2892. of /2022/
- what: The authors aim to summarize the present evidence on the treatment of localized SBA, including future perspectives.
- future: Given the characteristics shared with CRC SBA may also have a high ctDNA shedding rate which should be examined in future studies. Studies are required to define . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.